Panoro Minerals Ltd. Announces Brokered LIFE Offering for Gross Proceeds of up to C$5 Million NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Panoro Minerals Ltd. (“Panoro” or the “Company”) (TSX.V: PML), is pleased to announce that it has entered into an agreement with Red Cloud Securities Inc., who has agreed to act as lead agent and sole bookrunner on behalf of a syndicate of agents (collectively, the “Agents”), in connection with a “best efforts” private placement (the “M...
CORRECTION - Verde AgriTech Announces District Scale High-Grade Magnetic Rare Earths Discovery in Minas Gerais, Brazil SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF), please note: we updated the Appendix table to correct a presentation alignment. The column headings list the individual oxides in alphabetical order, followed by TREO and MREO; the data had appeared in the reverse order, which misaligned values with their headings. This update does not change the underlying assays or calc...
Verde AgriTech Announces District Scale High-Grade Magnetic Rare Earths Discovery in Minas Gerais, Brazil Continuous clay-hosted REE mineralised zone outlined. High-grade NdPr-rich samples return up to 8,930 ppm TREO and 2,182 ppm MREO. 22 samples return > 1,000 ppm MREO SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) ("Verde” or the “Company”), announces the delineation of a continuous clay hosted rare earth element (“REE”) mineralized zone (“the Zone”) in Alto Paranaíba, Minas Gerais, Brazil, covering ~5,500 hectares (or ~20 square miles) a...
Verde AgriTech Granted Patent for Advanced Fertilizer Production Technology Combining Glauconitic Siltstone and Beneficial Microorganisms SINGAPORE, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd. (TSX: NPK | OTCQX: VNPKF) ("Verde” or the “Company”), a specialty multi-nutrient potassium fertilizer innovator offering tailored solutions to support sustainable farming practices, is pleased to announce that its subsidiary Verde Fertilizantes LTDA has been granted a Brazilian patent (No. BR 10 2021 015788 7 - PROCESSO DE PRODUÇÃO DE FERTILIZANTE MINERAL EMPREGANDO INOCULAÇÃO COM ADITIVO...
Voyager to Present at Upcoming Investor Conferences LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference: Fireside chat at 4:00 p.m. ET on Tuesday, September 2, 2025, in Boston, MA, during which the company plans to highlight preclinical data supporting its non-viral delivery platform leveraging novel receptor-b...
Verde Announces Q2 2025 Earnings Results SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the period ended June 30, 2025 (“Q2 2025”). All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q2 2025: C$1.00 = R$4.08. Q2 2025 HIGHLIGHTS Operational and Financial Highlights Verde's sales volume in Q2 2025 was 80,354 tons; a 6% reduction compared to Q2 2024, which generated $4.8 million in revenue during the quarter.Gross margin excluding freight was 58% during the quar...
Voyager Reports Second Quarter 2025 Financial and Operating Results - Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs - - APOE program added to pipeline; fourth asset in industry-leading Alzheimer’s disease franchise - - 11 partnered programs with potential for $2.6B in development-stage milestone payments - LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported second quarter 2025 financial and op...
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach - New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s wholly-owned Alzheimer’s disease franchise now includes clinical-stage anti-tau antibody VY7523 as well as gene therapies targeting tau, amyloid, and APOE - LEXINGTON, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.